Cetuxumab ( C225 , Erbitux ), a monoclonal antibody directed against ligand binding in the extracellular domain of EGFR , inhibits tumor growth and is synergistic with chemotherapy and radiation .
Cetuxumab（C225，erbitux）是一种单克隆抗体，可竞争性结合EGFR细胞外配体区，抑制肿瘤生长，与放化疗有协同作用。
c225